ArticleViruses2025

In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication.

Cássia Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.